Peptides and peptide conjugates: therapeutics on the upward path.

Abstract

The main benefit of natural peptides, peptide analogs and newly designed peptides as therapeutics, lies in their high selectivity and affinity, which are frequently in the nanomolar range. New drugs targeting protein-protein interactions often require larger interaction sites than small molecules can offer. Thus, many peptidic drugs are already applied in… (More)
DOI: 10.4155/fmc.12.76

Topics

5 Figures and Tables

Cite this paper

@article{Ahrens2012PeptidesAP, title={Peptides and peptide conjugates: therapeutics on the upward path.}, author={Verena M Ahrens and Kathrin Bellmann-Sickert and Annette G Beck-Sickinger}, journal={Future medicinal chemistry}, year={2012}, volume={4 12}, pages={1567-86} }